Genes vs environment in inflammatory bowel disease: an update

References

• Torres J, Mehandru S, Colombel JF, et al. Crohn’s disease. Lancet. 2017;389:1741–1755.
   PubMed Web of Science ®Google Scholar
• Ungaro R, Mehandru S, Allen PB, et al. Ulcerative colitis. Lancet. 2017;389:1756–1770.
   PubMed Web of Science ®Google Scholar
• Levine A, Koletzko S, Turner D, et al. European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58:795–806.
   PubMed Web of Science ®Google Scholar
• Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17:1314–1321.
   PubMed Web of Science ®Google Scholar
• Everhov ÅH, Sachs MC, Malmborg P, et al. Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients. Scand J Gastroenterol. 2019;54:55–63.
   PubMed Web of Science ®Google Scholar
• Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390:2769–2778.
   PubMed Web of Science ®Google Scholar
• Abraham BP, Mehta S, El-Serag HB. Natural history of pediatric-onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol. 2012;46:581–589.
   PubMed Web of Science ®Google Scholar
• Henderson P, Rogers P, Gillett P, et al. The epidemiology and natural history of paediatric inflammatory bowel disease in a UK region: a prospective 14-year study. Arch Dis Child. 2012;97:A53.2–A54.
   Google Scholar
• Benchimol EI, Bernstein CN, Bitton A, et al. Trends in epidemiology of pediatric inflammatory bowel disease in Canada: distributed network analysis of multiple population-based provincial health administrative databases. Am J Gastroenterol. 2017;112:1120–1134.
   PubMed Web of Science ®Google Scholar
• Sýkora J, Pomahačová R, Kreslová M, et al. Current global trends in the incidence of pediatric-onset inflammatory bowel disease. World J Gastroenterol. 2018;24:2741–2763.
   PubMed Web of Science ®Google Scholar
• Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–1517.
   PubMed Web of Science ®Google Scholar
• Molodecky NA, Panaccione R, Ghosh S, et al. Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17:1792–1799.
   PubMed Web of Science ®Google Scholar
• Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347:911–920.
   PubMed Web of Science ®Google Scholar
• Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med. 2006;355:2226–2235.
   PubMed Web of Science ®Google Scholar
• Wang MH, Achkar JP. Gene-environment interactions in inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol. 2015;31:277–282.
   PubMed Web of Science ®Google Scholar
• Leso V, Ricciardi W, Iavicoli I. Occupational risk factors in inflammatory bowel disease. Eur Rev Med Pharmacol Sci. 2015;19:2838–2851.
   PubMed Web of Science ®Google Scholar
• Rogler G, Vavricka S. Exposome in IBD: recent insights in environmental factors that influence the onset and course of IBD. Inflamm Bowel Dis. 2015;21:400–408.
   PubMed Web of Science ®Google Scholar
• Fiocchi C. Integrating omics: the future of IBD? Dig Dis. 2014;32(Suppl 1):96–102.
   PubMedGoogle Scholar
• Cho JH, Brant SR. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology. 2011;140:1704–1712.
   PubMed Web of Science ®Google Scholar
• Moller FT, Andersen V, Wohlfahrt J, et al. Familial risk of inflammatory bowel disease: a population-based cohort study 1977-2011. Am J Gastroenterol. 2015;110:564–571.
   PubMed Web of Science ®Google Scholar
• Uhlig HH, Schwerd T, Koletzko S, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147:990–1007.
   PubMed Web of Science ®Google Scholar
• Cabré E, Mañosa M, García-Sánchez V, et al. Phenotypic concordance in familial inflammatory bowel disease (IBD). Results of a nationwide IBD Spanish database. J Crohns Colitis. 2014;8:654–661.
   PubMed Web of Science ®Google Scholar
• Tysk C, Lindberg E, Järnerot G, et al. Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut. 1988;29:990–996.
   PubMed Web of Science ®Google Scholar
• Halfvarson J. Genetics in twins with Crohn’s disease: less pronounced than previously believed? Inflamm Bowel Dis. 2011;17:6–12.
   PubMed Web of Science ®Google Scholar
• Halfvarson J, Bodin L, Tysk C, et al. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology. 2003;124:1767–1773.
   PubMed Web of Science ®Google Scholar
• Spehlmann ME, Begun AZ, Burghardt J, et al. Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study. Inflamm Bowel Dis. 2008;14:968–976.
   PubMed Web of Science ®Google Scholar
• Orholm M, Binder V, Sørensen TI, et al. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol. 2000;35:1075–1081.
   PubMed Web of Science ®Google Scholar
• Bengtson MB, Aamodt G, Vatn MH, et al. Concordance for IBD among twins compared to ordinary siblings–a Norwegian population-based study. J Crohns Colitis. 2010;4:312–318.
   PubMed Web of Science ®Google Scholar
• Gordon H, Blad W, and Trier Møller F, et al. UK IBD Twin registry: concordance and environmental risk factors of twins with IBD. Dig Dis Sci. 2022;67:2444–2450.
   PubMed Web of Science ®Google Scholar
• Annese V. Genetics and epigenetics of IBD. Pharmacol Res. 2020;159:104892.
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–606.
   PubMed Web of Science ®Google Scholar
• Cooney R, Baker J, Brain O, et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med. 2010;16:90–97.
   PubMed Web of Science ®Google Scholar
• Sabbah A, Chang TH, Harnack R, et al. Activation of innate immune antiviral responses by Nod2. Nat Immunol. 2009;10:1073–1080.
   PubMed Web of Science ®Google Scholar
• Lauro ML, Burch JM, Grimes CL. The effect of NOD2 on the microbiota in Crohn’s disease. Curr Opin Biotechnol. 2016;40:97–102.
   PubMed Web of Science ®Google Scholar
• Ashton JJ, Boukas K, and Stafford IS, et al. Deleterious genetic variation across the NOD signaling pathway is associated with reduced NFKB signaling transcription and upregulation of alternative inflammatory transcripts in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2022;28:912–922.
   PubMed Web of Science ®Google Scholar
• de Lange KM, Moutsianas L, Lee JC. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat Genet. 2017;49:256–261.
   PubMed Web of Science ®Google Scholar
• Liu JZ, van Sommeren S, Huang H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47:979–986.
   PubMed Web of Science ®Google Scholar
• Díez-Obrero V, Moratalla-Navarro F, and Ibáñez-Sanz G, et al. Transcriptome-wide association study for inflammatory bowel disease reveals novel candidate susceptibility genes in specific colon subsites and tissue categories. J Crohns Colitis. 2022;16:275–285.
   PubMed Web of Science ®Google Scholar
• Khera AV, Chan M, Aragam KG, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 2018;50:1219–1224.
   PubMed Web of Science ®Google Scholar
• Chen GB, Lee SH, Montgomery G, et al. Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method. BMC Med Genet. 2017;18:94.
   PubMed Web of Science ®Google Scholar
• Hollands GJ, Whitwell SC, Parker RA, et al. Effect of communicating DNA based risk assessments for Crohn’s disease on smoking cessation: randomised controlled trial. Version 2. BMJ. 2012;345:e4708.
   PubMedGoogle Scholar
• Kelsen JR, Sullivan KE, Rabizadeh S, et al. North American society for pediatric gastroenterology, hepatology, and nutrition position paper on the evaluation and management for patients with very early-onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2020;70:389–403.
   PubMed Web of Science ®Google Scholar
• Uhlig HH, Charbit-Henrion F, Kotlarz D, et al. Clinical genomics for the diagnosis of monogenic forms of inflammatory bowel disease: a position paper from the Paediatric IBD Porto Group of ESPGHAN. J Pediatr Gastroenterol Nutr. 2020;72:456–473.
   Web of Science ®Google Scholar
• Kammermeier J, Drury S, James CT, et al. Targeted gene panel sequencing in children with very early onset inflammatory bowel disease–evaluation and prospective analysis. J Med Genet. 2014;51:748–755.
   PubMed Web of Science ®Google Scholar
• Kelsen JR, Dawany N, Moran CJ, et al. Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease. Gastroenterology. 2015;149:1415–1424.
   PubMed Web of Science ®Google Scholar
• Nambu R, Warner N, Mulder DJ, et al. A systematic review of monogenic inflammatory bowel disease. Clin Gastroenterol Hepatol. 2022;20:e653–e663.
   PubMed Web of Science ®Google Scholar
• Marsh RA, Villanueva J, Zhang K, et al. A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency. Cytometry B Clin Cytom. 2009;76:334–344.
   PubMedGoogle Scholar
• Presicce P, Moreno-Fernandez ME, Lages CS, et al. Association of two clones allows for optimal detection of human FOXP3. Cytometry A. 2010;77:571–579.
   PubMedGoogle Scholar
• Tatsuki M, Hatori R, Nakazawa T, et al. Serological cytokine signature in paediatric patients with inflammatory bowel disease impacts diagnosis. Sci Rep. 2020;10:14638.
   PubMed Web of Science ®Google Scholar
• Wada T, Kanegane H, Ohta K, et al. sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency. Cytokine. 2014;65:74–78.
   PubMed Web of Science ®Google Scholar
• Bramuzzo M, Arrigo S, Romano C, et al.; SIGENP IBD Working Group. Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study. United European Gastroenterol J. 2019;7:759–766.
   PubMed Web of Science ®Google Scholar
• Romeo AC, Ventimiglia M, Dipasquale V, et al. Effectiveness and safety of biologics in pediatric inflammatory bowel disease: real-life data from the Sicilian network. Clin Res Hepatol Gastroenterol. 2020;44:223–229.
   PubMed Web of Science ®Google Scholar
• Piovani D, Danese S, Peyrin-Biroulet L, et al. Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses. Gastroenterology. 2019;157:647–659.e4.
   PubMed Web of Science ®Google Scholar
• Rozich JJ, Holmer A, Singh S. Effect of lifestyle factors on outcomes in patients with inflammatory bowel diseases. Am J Gastroenterol. 2020;115:832–840.
   PubMed Web of Science ®Google Scholar
• Wang Q, Xu KQ, Qin XR, et al. Association between physical activity and inflammatory bowel disease risk: a meta-analysis. Dig Liver Dis. 2016;48:1425–1431.
   PubMedGoogle Scholar
• Jones PD, Kappelman MD, Martin CF, et al. Exercise decreases risk of future active disease in patients with inflammatory bowel disease in remission. Inflamm Bowel Dis. 2015;21:1063–1071.
   PubMed Web of Science ®Google Scholar
• Jain A, Nguyen NH, Proudfoot JA, et al. Impact of obesity on disease activity and Patient Reported Outcomes Measurement Information System (PROMIS) in inflammatory bowel diseases. Am J Gastroenterol. 2019;114:630–639.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhu W, Gong J, et al. Visceral fat area is associated with a high risk for early postoperative recurrence in Crohn’s disease. Colorectal Dis. 2015;17:225–234.
   PubMed Web of Science ®Google Scholar
• Mahid SS, Minor KS, Soto RE, et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81:1462–1471.
   PubMed Web of Science ®Google Scholar
• Nunes T, Etchevers MJ, Domènech E, et al. Smoking does influence disease behaviour and impacts the need for therapy in Crohn‘s disease in the biologic era. Aliment Pharmacol Ther. 2013;38:752–760.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Long MD, Martin CF, et al. Sleep disturbance and risk of active disease in patients with Crohn’s disease and ulcerative colitis. Clin Gastroenterol Hepatol. 2013;11:965–971.
   PubMed Web of Science ®Google Scholar
• Weintraub Y, Cohen S, Chapnik N, et al. Clock gene disruption is an initial manifestation of inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2020;18:115–122.e1.
   PubMed Web of Science ®Google Scholar
• Ungaro R, Bernstein CN, Gearry R, et al. Antibiotics associated with increased risk of new-onset Crohn’s disease but not ulcerative colitis: a meta-analysis. Am J Gastroenterol. 2014;109:1728–1738.
   PubMed Web of Science ®Google Scholar
• Nguyen LH, Örtqvist AK, Cao Y, et al. Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden. Lancet Gastroenterol Hepatol. 2020;5:986–995.
   PubMed Web of Science ®Google Scholar
• Ortizo R, Lee SY, Nguyen ET, et al. Exposure to oral contraceptives increases the risk for development of inflammatory bowel disease: a meta-analysis of case controlled and cohort studies. Eur J Gastroenterol Hepatol. 2017;29:1064–1070.
   PubMed Web of Science ®Google Scholar
• Kaplan GG, Jackson T, Sands BE, et al. The risk of developing Crohn’s disease after an appendectomy: a meta-analysis. Am J Gastroenterol. 2008;103:2925–2931.
   PubMed Web of Science ®Google Scholar
• Deng P, Wu J. Meta-analysis of the association between appendiceal orifice inflammation and appendectomy and ulcerative colitis. Rev Esp Enferm Dig. 2016;108:401–410.
   PubMed Web of Science ®Google Scholar
• Nyboe Andersen N, Gørtz S, Frisch M, et al. Reduced risk of UC in families affected by appendicitis: a Danish national cohort study. Gut. 2017;66:1398–1402.
   PubMed Web of Science ®Google Scholar
• Chung WS, Chung S, Hsu CY, et al. Risk of inflammatory bowel disease following appendectomy in adulthood. Front Med (Lausanne). 2021;8:661752.
   PubMed Web of Science ®Google Scholar
• Milajerdi A, Ebrahimi-Daryani N, Dieleman LA, et al. Association of dietary fiber, fruit, and vegetable consumption with risk of inflammatory bowel disease: a systematic review and meta-analysis. Adv Nutr. 2021;12:735–743.
   PubMed Web of Science ®Google Scholar
• Day AS, Davis R, Costello SP, et al. The adequacy of habitual dietary fiber intake in individuals with inflammatory bowel disease: a systematic review. J Acad Nutr Diet. 2021;121:688–708.e3.
   PubMed Web of Science ®Google Scholar
• Milajerdi A, Mousavi SM, Sadeghi A, et al. The effect of probiotics on inflammatory biomarkers: a meta-analysis of randomized clinical trials. Eur J Nutr. 2019;59:633–649.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang F, Luo H, et al. Protective effect of butyrate against ethanol-induced gastric ulcers in mice by promoting the anti-inflammatory, anti-oxidant and mucosal defense mechanisms. Int Immunopharmacol. 2016;30:179–187.
   PubMed Web of Science ®Google Scholar
• Opstelten JL, de Vries JHM, Wools A, et al. Dietary intake of patients with inflammatory bowel disease: a comparison with individuals from a general population and associations with relapse. Clin Nutr. 2019;38:1892–1898.
   PubMed Web of Science ®Google Scholar
• Yang Y, Xiang L, He J. Beverage intake and risk of Crohn disease: a meta-analysis of 16 epidemiological studies. Medicine (Baltimore). 2019;98:e15795.
   PubMedGoogle Scholar
• Peters V, Bolte L, and Schuttert E, et al. Western and carnivorous dietary patterns are associated with greater likelihood of IBD-development in a large prospective population-based cohort. J Crohns Colitis. 2022;16:931–939.
   PubMed Web of Science ®Google Scholar
• Ge J, Han TJ, Liu J, et al. Meat intake and risk of inflammatory bowel disease: a meta-analysis. Turk J Gastroenterol. 2015;26:492–497.
   PubMed Web of Science ®Google Scholar
• Sugimura T, Wakabayashi K, Nakagama H, et al. Heterocyclic amines: mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci. 2004;95:290–299.
   PubMed Web of Science ®Google Scholar
• John S, Luben R, Shrestha SS, et al. Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study. Eur J Gastroenterol Hepatol. 2010;22:602–606.
   PubMed Web of Science ®Google Scholar
• Khalili H, Ananthakrishnan AN, Higuchi LM, et al. Early life factors and risk of inflammatory bowel disease in adulthood. Inflamm Bowel Dis. 2013;19:542–547.
   PubMed Web of Science ®Google Scholar
• Kayali S, Gaiani F, Manfredi M, et al. Inverse association between Helicobacter pylori and inflammatory bowel disease: myth or fact? Acta Biomed. 2018;89:81–86.
   PubMedGoogle Scholar
• Castano-Rodríguez N, Kaakoush NO, Lee WS, et al. Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis. Gut. 2017;66:235–249.
   PubMed Web of Science ®Google Scholar
• Arnold IC, Hitzler I, Muller A. The immunomodulatory properties of Helicobacter pylori confer protection against allergic and chronic inflammatory disorders. Front Cell Infect Microbiol. 2012;2:10.
   PubMed Web of Science ®Google Scholar